Propecia - an anti-hormonal drug. Used to reduce the size of the prostate gland, to increase the maximum speed of urine outflow, reducing the risk of developing acute urinary retention. The drug also turned out to be effective in the treatment of men’s alopecia.
Finpecia - potent pharmaceutical agent aimed to cure an illness named alopecia, of an androgenic as well as a hereditary genesis. Moreover, it stops the manifestation of various maladies deteriorating the advancement of the follicles and other difficulties connected with baldness.
Proscar - the drug is used to treat men’s baldness and benign prostatic hyperplasia. Inhibits the 5-alpha-reductase which converts testosterone into a more active 5-alpha-dihydrotestosterone, reduces its concentration in blood and prostate tissue.
Fincar - Cipla product, the main component of which is oriented to relieve the symptoms of the prostate enlargement - a malady during which a resized prostate results in a feeling of pain when urinating). The outcome from this medical agent is grounded on the lessening of the level of dihydrotestosterone in the male organism.
Finax (finasteride) is a drug designed to treat hair loss in men. This drug can slow down the process of baldness and promote the growth of new hair on the scalp in men who suffer from androgenic alopecia. It acts by blocking the activity of the enzyme 5-alpha-reductase in the body which prevents the formation of dihydrotestosterone (a male sex hormone that is the active form of testosterone, formed from testosterone in bodily tissue). The drug is also used in the treatment of difficulty urinating caused by a prostate adenoma (BPH, benign prostatic hyperplasia).
Finast is indicated for the treatment of benign proliferation of prostate tissue with the purpose of reducing its size and slowing the pathological process. The drug is successfully used to normalize the outflow of urine in case of a benign prostate enlargement and accompanying symptoms of hyperplasia. Finast is recommended for patients with benign enlargement of the prostate for the prevention of complications, urinary retention and the need for surgery. Under the influence of Finast, the level of dihydrotestosterone decreases in the blood and in the tissues of the prostate, but the drug does not affect the androgen receptors.